Share of first-cycle novel drug approvals
RecordSTO-KFKKPT8WMV-7SZNK97MNH-91JVAB
United States · 2024
Share of first-cycle novel drug approvals in the United States was 74% in 2024 (FDA).
New drug approvals in United States: every year, the rank and how it is measured
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- CDER’s Effectiveness Bringing New Therapies to Market
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
First Cycle Approvals: 37 of the 50 novel drugs approved in 2024 (74%) were approved on the “first cycle” of review.
Checked: the figure 74%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB
Other formats: MLA, Chicago, BibTeX
- MLA
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB.
- Chicago
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB.
- BibTeX
- @misc{fda2024share91jvab, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
- Type
- Press release
- Published
- —
- Locator
- CDER’s Effectiveness Bringing New Therapies to Market
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB